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Abstract
Natural tissues are incorporated with vasculature, which is further integrated
with a cardiovascular system responsible for driving perfusion of nutrient‐rich
oxygenated blood through the vasculature to support cell metabolism within
most cell‐dense tissues. Since scaffold‐free biofabricated tissues being devel-
oped into clinical implants, research models, and pharmaceutical testing
platforms should similarly exhibit perfused tissue‐like structures, we generated
a generalizable biofabrication method resulting in self‐supporting perfused
(SSuPer) tissue constructs incorporated with perfusible microchannels and
integrated with the modular FABRICA perfusion bioreactor. As proof of concept,
we perfused an MLO‐A5 osteoblast‐based SSuPer tissue in the FABRICA.
Although our resulting SSuPer tissue replicated vascularization and perfusion
observed in situ, supported its own weight, and stained positively for mineral
using Von Kossa staining, our in vitro results indicated that computational fluid
dynamics (CFD) should be used to drive future construct design and flow
application before further tissue biofabrication and perfusion. We built a CFD
model of the SSuPer tissue integrated in the FABRICA and analyzed flow
characteristics (net force, pressure distribution, shear stress, and oxygen
distribution) through five SSuPer tissue microchannel patterns in two flow
directions and at increasing flow rates. Important flow parameters include flow
direction, fully developed flow, and tissue microchannel diameters matched and
aligned with bioreactor flow channels. We observed that the SSuPer tissue
platform is capable of providing direct perfusion to tissue constructs and proper
culture conditions (oxygenation, with controllable shear and flow rates),
indicating that our approach can be used to biofabricate tissue representing
primary tissues and that we can model the system in silico.
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1 | INTRODUCTION
The ability to use biofabrication to accurately recreate natural
tissues and replicate their in situ environment in vitro with
bioreactors will lead to tissues which can (a) serve as accurate
research models of tissue activity, (b) act as early stage human tissue
testing platforms for pharmaceuticals in development without the
need for confounding animal models, (c) potentially produce
implantable tissues for clinical use, and (d) possibly serve as testing
platforms for animal humanization used to develop xenotransplants.
Like cells in natural tissues in situ, cells in biofabricated tissues
require consistent and adequate perfusion for nutrient‐dependent
cell metabolism, differential signaling, extracellular matrix (ECM)
deposition, and removal of metabolite wastes (Bonfiglio, Leungcha-
vaphongse, Repetto, & Siggers, 2010; Dimmeler, Haendeler, Ripp-
mann, Nehls, & Zeiher, 1996; Gan, Miocic, Doroudi, Selin‐Sjoögren, &
Jern, 2000; Kang & Chang, 2018). Natural tissues are comprised of
integrated vasculature by which cells in the tissue are perfused with
nutrient‐rich blood. Tissue vasculature is further integrated with the
cardiovascular system, which drives nutrient perfusion. Generating
biofabricated tissues exhibiting similar distributed vasculature‐like
structures integrated with a system capable of driving perfusion,
however, has proved to be an engineering, biological, and practical
challenge (Ball, Nguyen, Placone, & Fisher, 2016; Egger et al., 2017;
Goldstein, Juarez, Helmke, Gustin, & Mikos, 2001; Stiehler et al.,
2009; Wang, Wu, Wang, Lin, & Sun, 2009; Warren et al., 2009; Wu &
Ringeisen, 2010), which must be overcome to generate in vivo‐like
tissue structures (Carrier et al., 2002; Dennis, Smith, Philp, Donnelly,
& Baar, 2009; Guller, Grebenyuk, Shekhter, Zvyagin, & Deyev, 2016;
Maidhof et al., 2012).
Impeller‐driven spinner flask bioreactors provide perfusion by
flowing media over the tissue construct, which results in poorly
controlled and poorly defined perfusion to tissues within the bulk of
tissues or result in no perfusion within the bulk of solid tissues
(Radisic et al., 2004; Sikavitsas, Bancroft, & Mikos, 2002). In addition,
vortex breakdown may result in uneven mixing, resulting in uneven
nutrient distribution (Dusting, Sheridan, & Hourigan, 2006). Hollow
fiber bioreactors are comprised of perfusible, semipermeable hollow
fibers enveloped within a cartridge filled with cells and media. As
media flows through the fibers, there is a nutrient exchange between
the fibers and the cartridge space such that fresh nutrients
transferring into the cartridge are available to the cells and waste
from the cells are transferred out of the cartridge, and carried away
from the culture environment (Ye, Xia, Ferguson, Triffitt, & Cui, 2007;
Zhou, Shen, & Lauschke, 2019). While this approach does provide
controlled cellular perfusion, it is not suitable for solid tissues with
3D structures, which then need to be removed from the bioreactor.
Direct perfusion into porous tissues applies perfusive flow directly to
the open pores on the surface and through the bulk of a 3D tissue
construct (Egger et al., 2017; Gelinsky, Bernhardt, & Milan, 2015).
For constructs with nonuniform pore sizes and randomly oriented
pores, there are unknown flow paths, unknown conduit dimensions,
and unknown or poorly defined conduit shapes, thus increasing the
likelihood of producing unwanted turbulent flow, subnutritious flow
fields, and uneven nutrient distribution. For direct perfusion to
constructs with uniform pore sizes, the fact that the constructs are
scaffold‐dependent means that flow may be satisfactory but the cell
concentration is lower than what is observed in natural tissue, thus
limiting the construct’s suitability as a tissue (Moldovan, 2018).
Rotating vessel bioreactors keeps tissue constructs in the medium
filled vessel in a constant state of freefall by keeping the drag,
centrifugal, and gravitational forces in equilibrium, thereby providing
low shear stresses and high mass transfer rates (Porter, Lin, Peister,
Hutmacher, & Guldberg, 2007). The drawback to using them with
porous materials is the same as those presented by spinner flasks.
Compression bioreactors are also capable of promoting flow in tissue
constructs (Gelinsky et al., 2015; Kim, Sah, Grodzinsky, Plaas, &
Sandy, 1994). However, this method is most suitable to tissues
normally subjected to compression (musculoskeletal tissues) and the
force/strain (as much as 10%; Kim et al., 1994) of compression may
also result in damage or disintegration of initially delicate scaffold‐
free tissues.
We have developed the scaffold‐free self‐supporting and per-
fused (SSuPer) tissue method, whereby a perfusion module guides
nutrient flow directly into an array of microchannels built into the
tissue construct. Since the microchannels exhibit diameters and flow
paths prescribed by the tissue designer, our approach provides direct
and distributed nutrient perfusion to tissues within the tissue bulk.
The controlled diameter and flow path of the tissue microchannels
allow for accurate modeling of perfusion within the tissue construct
at different flow rates, with different flow media (i.e., blood, cell
culture media, etc., also described as “media of interest”) and for
different culture conditions (oxygen concentration, temperature,
flow rate, etc.). Furthermore, the SSuPer tissue design produces
scaffold‐free tissues comprised only of cells embedded within their
own cell‐secreted ECM, reproducing the composition and structure
of natural tissues, whereas other 3D biofabrication approaches are
normally comprised of reconstituted or synthetically derived
matrices, which limits their ability to integrate with the host tissue.
In this proof of concept, we describe how we used the SSuPer
tissue method to fabricate a SSuPer bone‐like tissue. Challenges with
our first trial indicated that computation‐based analysis could help
guide our tissue design (channel diameter and pattern) and
bioreactor implementation (flow rate, flow direction, and SSuPer
tissue integration with the bioreactor). Our goals are to (a) introduce
SSuPer tissues as a new method for generating generalizable, fully
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perfusible scaffold‐free tissue constructs, (b) demonstrate that we
can generate, perfuse, and culture, SSuPer tissues exhibiting
perfusible microchannels exhibiting a range of patterns and
diameters and, (c) with a computational model, demonstrate that
we can computationally model oxygen diffusion through SSuPer
tissue as a function of medium perfusion.
2 | METHODS
2.1 | Biofabrication (bioprinting, construction, and
culture) and analysis of a 3D‐bioprinted SSuPer tissue
As a proof of concept, a SSuPer bone tissue construct with various
channel diameters (Figure 1) was bioprinted and continuously
perfused for 2 weeks. Briefly, a Kenzan platen with perforations in
a 9 × 9 pattern was modified to serve as a base for the tissue
constructs (Figure 2a,b). The platen was aseptically coated with
0.15mg/ml collagen (Rat Tail Collagen Type 1; Becton Dickenson
Laboratories, Bedford, MA) for 1 hr, aspirating unbound collagen, and
allowing the platen to air dry for at least 1 hr before use. This platen
was then slotted onto a Kenzan needle array through its micro-
channels (Figure 2c,d) and then used for bioprinting tissue constructs
from cellular spheroids into tissue constructs (Figures 3 and 4;
Aguilar, Smith et al., 2019; Moldovan, Hibino, & Nakayama, 2017;
Smith, Li, Holland, & Ekser, 2018).
Tissue constructs were made using cell aggregates (spheroids)
made from murine MLO‐A5 cells. MLO‐A5 cells are late osteoblasts,
which produce large amounts of collagen that mineralizes into a
bone‐like structure in culture (Kato et al., 2001). Briefly, 12,000 to
13,000 cells/well were seeded into 96‐well plates with α‐modified
Eagle’s medium (α‐MEM) plus 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin (control medium). The cells were then
allowed to coalesce for 48–72 hr into 500‐µm diameter spheroids
(Moldovan et al., 2017). Construct design was achieved using the
Regenova (Cyfuse K.K., Japan) Bio 3D Printer’s construct design
feature. Following spheroid formation and construct design, the
Regenova bioprinter was used to bioprint/biofabricate a scaffold‐free
3D tissue construct as described by Aguilar, Smith, et al. (2019) and
Smith et al. (2018). Briefly, Regenova’s computer vision system
selects a suitable spheroid and the bioprinter’s mobile nozzle is then
moved close to the spheroid and negative pneumatic back pressure is
used to secure the spheroid to the nozzle tip and pick the selected
spheroid from the 96‐well plate. The nozzle is then moved over the
Kenzan (a microneedle array being used as a temporary support) and
then lowered to a predetermined height on a predetermined needle
positioned on the 9 × 9 Kenzan needle array according to the
predetermined construct design. Pneumatic back pressure is then
released from the nozzle, releasing the spheroid, which stays in
position on the Kenzan needle array at the designated height.
Spheroids were thus bioprinted onto the Kenzan to form three to
four spheroid high constructs with cross‐sectional pattern, as shown
in Figure 1. It should be noted that the terms “scaffold” or “scaffold‐
dependent” in bioprinting and biofabrication contexts are normally
used to describe cells embedded within ECM surrogate scaffolds
such as polymers or reconstituted proteins (i.e., collagen) or any non‐
cell material within the tissue that is not secreted from the cells
(Moldovan, 2018; Moldovan et al., 2017; Ozbolat, 2015). The
scaffold‐dependent tissue is therefore dependent on these scaffolds
to hold the tissue together over the long‐term. On the other hand,
scaffold‐free is normally used to describe tissues that are comprised
of cells embedded within their own cell‐secreted matrix (not
contrived or reconstituted ECM scaffolds) and are therefore
“scaffold‐free” (Aguilar, Olivos et al., 2019; Aguilar, Smith et al.,
F IGURE 1 Self‐supporting perfused
(SSuPer) tissue with various microchannel
sizes adhered to top platen. (a) The SSuPer
tissue (white) on the top platen (gray) has
200‐, 400‐, and 1,200‐µm wide channels.
(b) A larger diagram of the tissue
construct showing channel sizes and
patterns [Color figure can be viewed at
wileyonlinelibrary.com]
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2019; Blakely, Manning, Tripathi, & Morgan, 2015; Itoh et al., 2015;
Moldovan, 2018; Moldovan et al., 2017; Murata et al., 2015; Ozbolat,
2015; Toratani et al., 2017). The distinction between scaffold‐
dependent and scaffold‐free can similarly be defined by the tissue’s
final composition after maturation. Since the tissues are removed
from the needles in the Kenzan method after maturation and the
needles are not serving as ECM surrogates, the Kenzan method is, by
definition, a scaffold‐free method. The distinction is important since
the scaffold‐free Kenzan method results in self‐generated tissue
structures in a manner similar to natural tissue, unlike the scaffold‐
dependent method.
After incubating for 2 days, the collagen‐coated top‐platen was
slid into contact with the construct (Figure 3d–f), facilitating
adhesion of cells in the bottom layer of spheroids to ensure
adherence of the construct to the collagen‐coated platen. The
constructs are then allowed to adhere to the collagen‐coated
platen for 3 days of culture as the spheroids fused (Figure 3g–i).
With the construct still adhered in place, the platen was removed
from the Kenzan, leaving a SSuPer tissue construct with perfusible
microchannels (Figure 3j,k; construct feature dimensions are
provided in Supporting Information Material). While the larger
diameter microchannels (400 and 1,200 µm) are achieved by the
specific spheroid placement, the 200‐µm diameter microchannels
are a result of the spaces left by the Kenzan needles after Kenzan
removal, which approximate the diameter of Haversian Canals
(Cvetkovic et al., 2013). It should be noted, however, that the
SSuPer tissue method is intended to be generalizable to several
tissue types, not just bone. The 200‐µm microchannels are also
aligned with, and contiguous with, the channels in the supporting
platen, therefore serving as conduits for medium transport. During
the initial 5 days after bioprint, the spheroids also fused with one
another, forming an intact single tissue construct. Upon removal
from the Kenzan, the platen with the attached construct was
removed from the needles and secured, construct‐side‐up, to a
custom perfusion module and placed in a FABRICA Bioreactor
Platform (Smith et al., 2018) so that medium can flow through the
FABRICA’s integrated perfusion channels (Smith et al., 2018)
and perfuse the construct (Figure 4a–d). For 2 weeks, a
peristaltic pump connected to the FABRICA was used to perfuse
osteogenic cell culture media composed of α‐minimum essential
medium (α‐MEM) supplemented with 10% serum, 4–5 mM
β‐glycerophosphate, and 100 ug/ml ascorbate at 0.5 ml/min.
Culture medium was exchanged twice a week during perfusion.
After perfusion, the SSuPer tissue was fixed with 4% formalin,
removed from the platen, embedded in optimal cutting tempera-
ture (OTC) medium, and frozen. The frozen samples were cut
5–10 µm thick, and stained with hematoxylin and eosin and Von
Kossa. Briefly, Von Kossa staining for phosphate deposits was
achieved by rinsing the sections with water, incubating the
sections with 1% silver nitrate under ultraviolet light, followed
by rinses with water and sodium thiolsulfate. Phosphate deposits
show up at black stains (Kato et al., 2001).
(a) (b)
(c) (d)
F IGURE 2 The top platen is used to align microchannels in bioprinted tissues and guide flow into microchannels during perfusion. (a) The top
of the top platen is coated with collagen to facilitate cellular spheroid adhesion. (b) Microchannels pass through the platen and can facilitate
needles or flow. (c,d) For bioprinting the SSuPer tissues, the platens can easily be slotted over the needles of the Kenzan base. SSuPer, self‐
supporting perfused [Color figure can be viewed at wileyonlinelibrary.com]
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2.2 | Tissue model design for computational fluid
dynamics analysis
SSuPer tissue models with representative microchannel patterns shown
in Figure 5a–e were generated using Autodesk Inventor (Autodesk, Inc.,
CA) in silico as .ipt files and converted to .stl files. The channel patterns
included a design with 81 channels, each 200 μm in diameter, square‐
packed in a 9 × 9 arrangement and spaced 400 μm apart, to a design
with 1 channel 2.0mm in diameter. Specific pattern dimensions are
provided in the Supporting Information Material. Each SSuPer tissue
design had the same overall dimensions of 1mm×3.6mm×3.6mm
(Figure 5f). The pattern designs represent axis‐symmetric tissue design
cross‐sections currently possible with the Regenova Bio 3D printer
(Cyfuse, Japan). Although the tissue construct patterns were changed,
the pattern of the Kenzan platen’s underlying perfusion microchannels
was kept to the same 9 × 9 pattern.
F IGURE 3 SSuPer tissue biofabrication onto the Kenzan with the Regenova Bio 3D printer. (a–c) In the print step, the Regenova places
spheroids onto the Kenzan needles in a preselected pattern and are held in place by friction. (d–f) After 2 days, as the spheroids fuse, the platen
is slotted into contact with the forming tissue construct such that cells in the construct adhere to the collagen coating on the platen. (g–i) The
spheroids fully fuse, forming a tissue construct on the platen. (j, k) With the spheroids fully fused into a tissue construct and adhered to the top
platen, the tissue‐platen complex is removed from the Kenzan base with the holes left in the construct from the Kenzan needles forming
perfusible microchannels aligned and contiguous with the microchannels in the platen. The resulting construct is a SSuPer tissue. SSuPer,
self‐supporting perfused [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 4 The SSuPer tissue and its integrated perfusion microchannels are perfused in the FABRICA Bioreactor platform for weeks at a
time. (a) A perfusion module is secured in the flow path within the FABRICA internal chamber and the platen containing the SSuPer tissue is
secured to the perfusion module. Flow ports lead to and from the peristaltic pump. (b) Flow passes into and out of the internal chamber through
internal channels (blue arrows). (c) and (d) are cutaways and close‐ups showing the path media flows to perfuse through the SSuPer tissue. Flow
can travel into our out of the internal inlet, depending on desired flow direction. SSuPer, self‐supporting perfused [Color figure can be viewed at
wileyonlinelibrary.com]
F IGURE 5 Proof‐of‐concept SSuPer tissue. (a) Bioprinted proof‐of‐concept SSuPer bone tissue after removal from Kenzan needle array.
(b) Bioprinted tissue design and dimensions. SSuPer tissue microchannel patterns. (a) 4‐channel pattern. (b) 16‐channel pattern. (c) 1‐channel
pattern. (d) 81‐channel pattern. (e) Hybrid pattern. (f) Orthogonal view with overall tissue dimensions. All units are in mm. SSuPer,
self‐supporting perfused [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 6 Model setup. (a) Original FABRICA CAD design with a bioprinted SSUPer tissue construct mounted within. (b) Cutaway view of
computational domain derived from original CAD design, with labeled boundary surfaces (inlet, outlet and environment). (c) Detailed view of
subdomain for the construct, for the case of 81 flow channels. (d) Cutaway view of computational domain mesh for representation of fluid flows.
(e) Select views of model mesh. The flow domain is shown in yellow, and the construct domain is shown in green. (f) Detailed view of flow
channels through the platen. (b) Detailed view of channels through the construct, for the case of 81 flow channels. (g) Detailed view of inlet and
outlet regions of the flow domain. SSuPer, self‐supporting perfused [Color figure can be viewed at wileyonlinelibrary.com]
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2.3 | CFD analysis
2.3.1 | Model and mesh
The three‐dimensional model, including the FABRICA bioreactor
(Smith et al., 2018) and the SSuPer tissue perfusion model, was
imported into Ansys v.16 (ANSYS, Inc., PA; Figure 6a–g), for analysis
using CFX simulation suite. Separate model geometries were
generated for the tissue construct/bioreactor and flow domain.
Fluid–solid interactions were not included in this model and the
construct was modeled as a rigid solid without surface defects and
perfectly bonded to the platen. To simulate cellular respiration, a
uniform oxygen source rate was applied to the construct domain.
Advection in the flow domain was modeled assuming laminar flow
and the system was numerically solved for steady‐state conditions.
Five boundaries for the flow domain were identified, each with
separate boundary conditions:
1. The interface with the construct, where the condition of no fluid
flow was applied.
2. An arbitrarily selected cross‐section of the bioreactor‐SSuPer
tissue inlet flow path, where normal flow rate and oxygen
concentration were specified as design parameters.
3. An arbitrarily selected cross‐section of the bioreactor‐SSuPer
tissue outlet flow path, where normal flow rate and oxygen
concentration were calculated.
4. The interface with the environment of the bioreactor‐SSuPer
tissue, where the condition of no normal flow was applied and
oxygen concentration was specified as a design parameter.
5. The interface with all parts of the bioreactor‐SSuPer tissue, where
the conditions of no fluid flow or normal oxygen transport were
applied.
To characterize flow behavior in the FABRICA bioreactor and
within the 3D‐bioprinted tissues, (a) inlet flow rates were simulated
at logarithmic intervals of 0.1, 0.5, 1.0, 5.0, and 10ml/min,
representing a broad range of flow rates possible in the FABRICA
system for all media of interest (Table 1) and atmospheric oxygen
inputs of 9.4 mol/m3 (21% oxygen at standard temperature and
pressure), (b) shear stress at the construct interface was measured in
all flow channels along the direction of flow in the normal plane
halfway through the construct, the mean and standard deviation of
which were recorded, (c) differential pressure across the entire
SSuPer tissue was calculated by measuring the relative pressure at
the FABRICA inlet and outlet and oxygenation of the construct was
determined by recording the mean and standard deviation of oxygen
concentration throughout the construct domain. To quantify con-
struct stability, the net force exhibited by fluid flow on the construct
was calculated and recorded. Two flow direction scenarios were
analyzed. The forward (first) flow direction involved the flow medium
traveling through the platen and into the construct (from inlet to
outlet). Backwards (second) flow involved the flow medium traveling
initially through the construct and then through the platen (from
outlet to inlet).
Mapped meshing and mesh refinement were performed through-
out the model using tetrahedral and hexahedral elements
(Figure 6d–g). To capture the diffusive flux of oxygen into the
construct, as many as three columnar layers of thin hexahedral
elements were extruded into the construct from the interface with the
flow channels. Thin, hexahedral elements were also extruded into the
flow channels to capture the development of boundary layers
according to typical laminar flow in pipes. Layers of hexahedral
elements were also mapped to, and extruded from, the interface of the
construct not in contact with the flow channels, to capture oxygen
transport between the construct and chamber of the FABRICA. Thin
elements were extruded into the flow domain from boundaries near
the inlet and outlet of the FABRICA, to capture highly directional flow
in these regions. The mesh consisted of a total of between 800,000
(one channel) and 1,050,000 nodes (81 channels).
2.3.2 | Material properties
Diffusivity of oxygen in the construct and all fluids of interest (media)
were taken from the literature (Table 1), and construct metabolic
activity was calculated using data reported in the literature for
average oxygen consumption rates of human cells ([25 attomol O2/
cell/s]; McMurtrey, 2016) and a cellular density of 12k cells per
spheroid of 500 µm diameter. Properties, including density, dynamic
viscosity, and oxygen diffusivity for all three media fluids were
TABLE 1 Material properties
Working fluid Density (kg/m3) Dynamic viscosity (mg·m−1·s−1) O2 diffusivity (µm
2/s)
Water 993.3 (“Viscosity of Water,”
2018)
691.2 (“Viscosity of Water,” 2018) ~3,300 (Ferrell & Himmelblau, 1967)
Cell culture medium + 10%
FBS
1,000 940.0 (Fröhlich et al., 2013) 2,690 (Zhang et al., 2014)
Blood ~1,060 (Sniegoski & Moody,
1979)
2,798 (Anton Paar, n.d.) 1,620 (Goldstick, Ciuryla, & Zuckerman,
1976)
Density (kg/m3) O2 consumption rate (µmol·m
−3·s−1) O2 diffusivity (µm
2/s)
Construct 1,000 458.4 (McMurtrey, 2016) 2,500 (McMurtrey, 2016; Zahm et al.,
2010)
Abbreviation: FBS, fetal bovine serum
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retrieved from the literature as previously reported (Fröhlich et al.,
2013). For values cited in the literature reporting kinematic viscosity,
the dynamic viscosity was calculated as the kinematic viscosity
multiplied by the fluid density. The construct was assumed to have a
density slightly greater than water (Table 1).
3 | RESULTS
3.1 | Bioprinted SSuPer tissue
The SSuPer construct remained on the platen after Kenzan removal
(Figure 7a), during placement onto the perfusion module within the
FABRICA. The SSuper tissue was supporting its own weight
throughout Kenzan removal, transfer, placement, and perfusion
(Figure 7a,b). After 2 weeks of perfusion, the SSuPer tissue continued
to remain intact and support its own weight but was partially
separated from the platen (Figure 7c). The lifted portion was also
supporting its own weight even after removal from the culture
medium (Figure 7d). Histological sections exhibited Von Kossa
staining indicative of phosphate deposition in regions associated
with the 200‐μm microchannels left by the needles (Figure 7e).
Preliminary studies, not shown, indicate that the channels remain
patent throughout the incubation period. Thus, it is likely the
microchannels collapsed during histological preparation. The center
of some of these Von Kossa stained features were spaced
approximately 400 μm from one another, commensurate with the
spacing of the 200 µm microchannel spacing of the platen and tissue
patterns. The larger 400‐µm and 1,200‐µm diameter perfusion
channels in the SSuPer tissue did not exhibit Von Kossa staining.
3.2 | Shear stress
Shear stresses generated in the CFD model of the 3D tissue
microchannels were dependent on construct design, channel dia-
meter, and flow velocity. The two lowest maximum magnitudes of
shear stress in the mid‐plane among all trials were measured in the
four‐channel construct at 0.1 ml/min in the forward (flow from
internal inlet to internal outlet or flow in the +y direction; 2.270mPa)
and reverse (flow from internal outlet to internal inlet or flow in the
–y direction; 2.243mPa) directions, while the greatest two were
achieved in the 81 channel constructs at 10ml/min in the forward
(2.610 Pa) and reverse (2.583 Pa) directions. Shear stresses were
observed to be uniform throughout the channels of the 81‐channel
design, except at the upper‐most surface of the construct. Significant
gradients were observed near the platen channels for all other
designs and both flow directions (Figure 8a,b) due to the sudden
F IGURE 7 3D‐Bioprinted SSuPer tissue. The tissue is outlined in red in Figure 4a–d. (a) SSuPer tissue on the platen following removal from
the Kenzan but before perfusive culture. (b) SSuPer tissue installed in perfusion module within FABRICA bioreactor just before perfusive
culture. (c) The SSuPer tissue partially lifted from platen as shown from the top down view after 2 weeks of perfused culture. (d) The SSuPer
tissue after 2 weeks of perfused culture in the FABRICA shown from the top view is capable of supporting its own weight after removal from
the bioreactor. The left corner is being supported by the tissue’s mechanical integrity. (e) Histological section of SSuPer tissue. Black regions
marked with white arrows are Von Kossa stained for phosphate and represent the 200‐µm microchannels. Regions marked by black arrows are
presumed to be microchannels without mineralization. SSuPer, self‐supporting perfused [Color figure can be viewed at wileyonlinelibrary.com]
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change in flow path to/from the platen. As such, gradients were more
widespread on construct surfaces with increasing flow rate for all
designs except the 81‐channel. This was particularly true in the
forward direction, where Eddy currents were observed in the
construct channels. In the most extreme case, Eddy currents
(turbulent flow) occupied approximately half the length of the
construct channels for the 16‐channel design at 10ml/min
(Figure 8c), while turbulence only occurred at the upper‐most
surface of the construct for the same flow rate and reverse direction
(Figure 8d).
F IGURE 8 Shear stress on surfaces of the construct along the −y direction, for hybrid microchannel design perfused with α‐modified Eagle’s
medium (α‐MEM) and forward inlet flow rates of 0.1 ml/min (a) and 10ml/min (b). Detailed view of velocity vectors for flow through two
channels for 16‐channels, α‐MEM and 10ml/min. Inlet flow in the forward (c) and reverse (d) directions. Eddy currents formed across
approximately half the length of the channels in the forward direction. (e) Gauge pressure distribution in the −xy plane for one flow channel
construct, α‐MEM and 10ml/min forward inlet flow. The construct in the inset is outlined by the dotted red line [Color figure can be viewed at
wileyonlinelibrary.com]
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3.3 | Pressure
Gauge pressure was calculated and recorded for all construct designs,
fluids of interest, flow rates, and directions. Results showed an expected
pressure drop across the flow channels in the platen and construct. For
construct designs with sudden changes in flow path, no significant
pressure gradients were observed for all fluids and flow rates and
directions. However, for construct designs that blocked some flow paths
of the platen, blocked platen channels induced additional upward forces
on the construct for flow in the forward direction, contributing to
compromising construct stability (Figure 8e).
3.4 | Oxygen
Oxygen distribution through the construct and medium volume
(Figure 9a–d) was saturated for all designs and flow rates. The mean
and standard deviation of specific oxygen throughout the construct
were calculated and recorded. The mean oxygen minus three
standard deviations was compared to the inlet specific oxygen, the
ratio of which was used as an oxygenation metric. Varying
microchannel pattern, flow rate, and direction, the least efficient
configuration was the single channel for 0.1 ml/min in the forward
direction (oxygenation metric of 0.9929), while the most efficient was
F IGURE 9 Relative oxygen distribution in the −xy plane for an 81‐channel construct perfused with α‐MEM at an inlet flow rate of 0.1 ml/min
in the forward (a) and reverse (b) directions. Note the gradual decrease in oxygen concentration along the length of the construct microchannels
as well as difference in minimum and maximum oxygen levels throughout the distribution, which varies by less than 1%. (c) and (d) are
magnifications of (a) and (b), respectively. (e) Forces on a construct with a four‐channel design, α‐MEM, and 10ml/min flow along the −x (left),
−y (middle), and −z (right) directions, for forward (top) and reverse (bottom) flow. Images of other patterns are available in the Supporting
Information Material. α‐MEM, α‐modified Eagle’s medium [Color figure can be viewed at wileyonlinelibrary.com]
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the hybrid design for 10ml/min in the forward direction (oxygenation
metric of 0.9996). Varying fluid, flow rate, and direction for the
81‐channel design, the least efficient configuration was blood for
0.1 ml/min in the reverse direction (oxygenation metric of 0.9990),
and the most efficient was water for 10ml/min in the forward
direction (oxygenation metric of 0.9996).
3.5 | Force distribution
Force distributions on all construct surfaces were calculated and
evaluated to determine factors affecting construct stability
(Figure 9e). Variations were observed in the distribution of vertical
(y−) forces on the top (xz‐planar) surface of construct for both flow
directions, while the primary forces lateral to channel flow were
uniformly distributed over the external, vertical (xy− and yz‐planar)
surfaces of the construct. Comparing vertical force distributions for
the same flow rate and opposite directions, distributions were
comparable but of opposite sign, implying that construct stability
may be primarily due to construct design and resulting flow, as well
as flow direction.
Select scalar measurements of simulation configurations provided
quantitative insights into the effects of channel design and flow rate and
direction on construct stability and viability (Figure 10). Anticipated
changes in direction, shear stress, and net force along the vertical axis
were observed. For the 16‐channel design, the effects of Eddy currents
were clearly observed for forward flow at 10ml/min, where turbulent
flow occupied over half the length of the channels and caused negative
shear forces at the mid‐height of the construct (Figure 10a,d).
Otherwise, measured shear stress in the channels behaved predictably,
with increases proportionate to channel flow speed. Measured pressure
drop across the SSuPer tissue exhibited a slightly nonlinear response
but was below 0.5 kPa for all simulated configurations (Figure 10b). The
nonlinear behavior of the pressure drop likely occurred due to the
combination of turbulence within the construct channels, as well as
changes in flow throughout the bioreactor‐SSuPer tissue complex.
F IGURE 10 Scalar metrics of interest for α‐MEM in the forward (solid, circles) and reverse (dashed, squares) directions and all construct designs
(light blue: 81 channels, orange: 16 channels; gray: four channels; yellow: one channel; dark blue: hybrid). (a) Mean shear on the channels along the −y
direction halfway along the channels. (b) Pressure drop across the mechanism, measured from the inlet to the outlet. (c–e) Net force on the construct
in the −x (c), −y (d), and −z (e) directions. α‐MEM, α‐modified Eagle’s medium [Color figure can be viewed at wileyonlinelibrary.com]
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However, no significant changes were observed between forward and
reverse flow directions. Lateral (x− and z−; Figure 10c,e) net forces on
the construct were of negligible magnitude compared to vertical net
force, suggesting that experimentally observed construct instability may
be due to imperfections in the construct surface or shear separating the
construct from the platen, rather than the devised flow regimes of the
mechanism. A sudden change in lateral forces did occur with increasing
flow rate in the reverse direction, somewhere above 5ml/min. The
geometry of the flow domain sufficiently altered the flow path to
produce measurably consistent differences at the construct.
The effects of working fluid on construct stability and viability were
also analyzed for the 81‐channel design while varying fluid parameters,
flow rate, and direction (Figure 11). As expected, measured vertical
shear in the channels and net force on the construct increased with
increasing fluid viscosity and aligned with the direction of flow, but
otherwise behaved predictably (Figure 11a,d). Pressure drop across the
mechanism behaved nearly linearly, demonstrating the possibility to
estimate the amount of turbulent flow occurring in the channels as
deviations from linearity between flow rate and pressure drop
(Figure 11b). Fluid viscosity also expectedly caused increases in
pressure drop, while flow direction had negligible effects. Lateral forces
exhibited similar, negligible behaviors to those observed while varying
construct design, except that increasing fluid viscosity increased the
range at which the geometry of the flow domain caused measurable
changes in flow at the construct (Figure 11c,e). Lateral forces were
also observed to decrease with increasing viscosity, however negligible
the scale.
4 | DISCUSSION
4.1 | Fully developed flow and reduced turbulence
promoted by matching platen and tissue
microchannel diameters
The 81‐channel pattern allows for fully developed flow since the
diameters between the platen and the SSuPer tissues are the same,
also discouraging significant Eddy currents. Eddy currents, indicative
F IGURE 11 Scalar metrics of interest for 81 channels in the forward (solid, circles) and reverse (dashed, squares) directions and all working fluids
(light blue: water, orange: DMEM; gray: blood). (a) Mean shear on the channels along the −y direction halfway along the channels. (b) Pressure drop
across the mechanism, measured from the inlet to the outlet. (c–e) Net force on the construct in the −x (c), −y (d), and −z (e) directions [Color figure
can be viewed at wileyonlinelibrary.com]
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of turbulence, do not represent the predominant flow profile in vivo
as turbulence is mechanically damaging to the tissue and can
interfere with nutrient transfer. One approach to reducing the
development of Eddy currents and achieving fully developed flow
throughout the bioprinted tissue is to design SSuPer tissue pattern‐
matched platens to match each construct pattern. In addition, fully
developed flow through the constructs can be achieved by using an
appropriately thick platen, and thus microchannels. The length
required to achieve this flow condition, which is normally positively
correlated with channel diameter, can be determined using fluid
mechanics with variables such as channel profile, viscosity, and
flow rate.
4.2 | The current CFD model can account for
oxygen diffusion and potential cellular oxygen
consumption
The model exhibits a gradual change in oxygen concentration along
the length of the tissue microchannels. Since the tissue is oxygen‐
saturated at steady state, the decreases in oxygen concentration are
the result of oxygen consumption, indicating that the CFD model can
be used to determine if tissues used in the bioreactor are receiving
adequate oxygenation. The average cell oxygen consumption rate
used in this model resulted in negligible reductions in oxygen
concentration. However, predicted cell oxygen consumption rates
span three orders of magnitude, which suggests that oxygen
depletion using the current bioreactor setup may occur when using
highly consumptive cell types. Increased cell densities, larger tissues,
and cell proliferation within the construct (if any) after bioprint
can also contribute to increased oxygen demand. Therefore, when
culturing tissues in vitro, it is critical to know the oxygen
consumption rate of the cells (bone cells, liver cells, etc.), resultant
tissue being cultured, if proliferation is occurring, as well as the
oxygen concentration in the culture medium. In some cases, as we
are investigating in ongoing studies, it may be prudent to further
oxygenate the medium to ensure there is oxygen available for
increased cell metabolic demands.
4.3 | There are increased benefits of using
“reversed” flow regarding oxygenation and
tissue‐platen integrity
4.3.1 | Oxygenation
As the force generated on the SSuPer tissue during forward
perfusion can potentially push the tissues off of the platen, reverse
flow could draw the tissue to the platen, preventing loss of the
construct. The model shows that reverse flow results in minimal Eddy
currents at the microchannel inlet, leading to developed flow through
most of the microchannel length. However, if the tissue is not
mechanically robust enough to withstand the stresses applied to it
during reverse flow, there is a possibility that the channels will
collapse. A possible approach is to initiate perfusion at a very low
flow rate to provide nutrient access until the construct develops
sufficient integrity to support increased pressure at flow rates
needed for the study.
Oxygen distributions also demonstrated that the difference in
volume of the flow regions above and below the platen and construct
exhibits a sort of “reservoir” effect on convection of diffusive species
with respect to the larger flow region. In terms of a lumped element
model, gradients of the oxygen distributions imply that the larger of
the two volumes can be thought of as having a greater capacitance
with respect to diffusive mass transport, the resulting distributions in
which are affected by forced flow and the upper, environmental
boundary. In the case of forward flow, the larger flow volume acts
like a sink for diffusive mass transport of oxygen. In the case of
reverse flow, the larger flow volume acts like an oxygen reservoir.
Oxygen distributions showed that the larger perfusion volume of
the mechanism (above the platen) demonstrates a greater capaci-
tance for diffusive mass transport. This finding is particularly relevant
for two reasons. First, the top of the construct generally has a greater
interfacial area with the larger flow volume (because the platen
blocks the bottom), and increasingly so for larger constructs. While
results did not demonstrate any immediate way to precisely quantify
these effects, what is clear is that their effects will likely be more
pronounced for larger and more metabolically demanding constructs,
and for flow rates nearly too low to provide sufficient nutrient
delivery. For this consideration, the upper, environmental interface
provides a second control mechanism for gaseous species through
control of the environment in which the entire mechanism is placed.
Second, metabolic waste produced by the construct must also be
removed. In the case of insufficient advection, reverse flow then
likely presents the greater possibility of waste products being drawn
into the construct compared to forward flow.
4.4 | Flow‐induced shear stress developed in
SSuPer tissue show potential for regulating cell and
tissue behavior
There were, in effect, three microchannel diameters analyzed in the
SSuPer tissue used as proof of concept. The fact that only tissue
surrounding the smallest diameter channel exhibited mineralization
supports the concept that perfusion induced shear stress can
modulate osteogenesis (Sawyer et al., 2018).
Similar to cells in vivo, in vitro cell response to fluid shear is
dependent on the shear level and the cell type (Wittkowske, Reilly,
Lacroix, & Perrault, 2016). Osteocytes in natural bone are subject to
shear stress levels between 0.8 and 3 Pa (Weinbaum, Cowin, & Zeng,
1994). MLO‐Y4 cell (an early osteocyte line) exposure to fluid shear
stresses in the 0.2–2 Pa range have exhibited increased osteocytic
responses including ATP (Genetos, Kephart, Zhang, Yellowley, &
Donahue, 2007), calcium2+, (Genetos et al., 2007; Lu, Huo,
Park, & Guo, 2012), Cox2 (Ponik, Triplett, & Pavalko, 2007), SOST
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(X. Li et al., 2013), and osteopontin (Ponik et al., 2007) upregulation
while higher fluid shear stresses (in the 3.0‐Pa range) applied to
MLO‐Y4 cells have resulted in decreased cell viability (X. Li et al.,
2013). Similarly, MLO‐Y4s show decreasing RANKL and increasing
COX‐2 as shear increases from no flow to 1 to 5 Pa (J. Li, Rose,
Frances, Sun, & You, 2012). For cardiac tissue, shear stresses greater
than 0.25 Pa have been shown to cause cellular damage and reduce
cell expansion (Barash et al., 2010; Brown, Iyer, & Radisic, 2008;
Lecina, Ting, Choo, Reuveny, & Oh, 2010; Teo, Mantalaris, & Lim,
2012). For bone‐marrow mesenchymal stem cells, a shear level of
0.5 Pa has been shown to inhibit proliferation and, in some cases,
push the stem cells toward osteogenic differentiation. The average
shear rates achieved for 0.1 to 10ml/min flow in both flow directions
in our 81‐channel SSuPer tissue model range from 0.067 to 7.58 Pa
for blood and from 0.02281 to 2.56 Pa for culture media. The shear
rates achieved with our model indicate that our system should be
able to provide the optimal shear environment for biofabricated bone
and cardiac tissues.
Since the CFD model allows the determination of shear stress
within the microchannels, a possible future study will be to test more
SSuPer tissues with consistent microchannel diameters and test at
increasing flow rates to determine the minimal shear rate required to
invoke osteogenesis and mineralization.
5 | CONCLUSION
5.1 | Key innovations
A key innovation of the present study is the adhesive coupling of the
3D‐bioprinted tissue construct to the platen while aligning the 200‐µm
diameter tissue microchannels with the platen microchannels. Instead
of allowing the holes to close, thus limiting nutrient access to the
tissue bulk, we have effectively used the needles to generate the
smallest perfusible biofabricated conduits ever produced in a scaffold‐
free bioprinted tissue and we have also demonstrated biological
activity as a result of their perfusion. Spacing between microchannels
ensures nutrient access throughout the tissue (Grimes, Fletcher, &
Partridge, 2014). To our knowledge, this is the first demonstration of a
bioprinted tissue supporting its own weight with self‐secreted matrix
during continuous perfusion without support from biomaterial
scaffolding. We have demonstrated, using constructs made from
IDG‐SW3 cell spheroids, that SSuPer tissue microchannels maintain
their patency over the course of bioreactor culture (perfused or non‐
perfused) for up to 3 weeks (unpublished). Although Von Kossa alone
is not sufficient to confirm in vitro mineralization (Bonewald et al.,
2003), the localization of the staining to only the smallest channels and
not the tissue perimeter suggests that phosphate staining is due to
cellular deposition of mineral. Fourier transform infrared spectroscopy
or other analyses should, however, be used to verify calcium
phosphate presence and quality (Bonewald et al., 2003).
Although researchers have thoroughly investigated perfusion and
predicted drug uptake using CFD analysis of naturally derived tissues
(d’Esposito et al., 2018), the CFD analysis of bioprinted SSUPer
tissues perfused in the FABRICA bioreactor represents a new
paradigm in utilizing tissue models and bioreactor platforms for
research, clinical, and drug development (d’Esposito et al., 2018)
applications while providing a scalable, modular, and integrated
platform for tissue engineering in general. With the capability of our
team to fabricate bone‐like (as demonstrated in this manuscript),
liver‐like (Gao et al., 2001), and other tissues (in development), the
great potential in the platform described is that it can be
implemented with human cell‐based SSuPer tissues and perfused
with drugs, meaning the platform can be used for preclinical in vitro
drug testing of drug candidates. Since in vivo animal models do not
accurately represent human biology, the ability to test scaffold‐free
3D human tissues will elucidate potential clinical outcomes while also
allowing varied patient populations to be studied before testing in
humans. The platform therefore has the potential to reduce drug
recidivism in the clinical trial phase. Methods for producing a 3D
tissue model further representative of the natural tissue include
accounting for the heterocellular cell composition, and thus
combination of metabolism of different cell types, as observed in
natural tissues, as well as inputting CFD medium flow rates matched
to the in situ flow rates for the tissue being studied.
Another exciting future approach is to include vascular cells in the
tissue construct to line the microchannels to replicate the vascular cell
composition and structure found in all vascularized tissues. The flow
velocities implemented by the flow system and input into the CFD
model are within the operational envelope of our bioreactor system
and match closely with physiological vascular flow rates (Groth et al.,
1995). While the range of vascular channel diameters in the natural
vasculature is between 5 and 10mm, tissue construct design was
limited to the range of diameters on the original platen. Future work
regarding this platform includes controllable oxygen provision, a
complete study of SSuPer tissues in vitro using the FABRICA
bioreactor, and data from this CFD model. In theory, however, the
SSuPer tissue concept and the FABRICA are limited to neither the
platen dimensions nor the Kenzan method, which means the concept
can be scaled up or down to accommodate different tissue dimensions.
Ongoing work therefore includes developing SSuPer tissue biofabrica-
tion methods, which do not rely on the Kenzan method, facilitating
widespread adoption of SSuPer tissues as a research tool.
5.2 | SSuPer tissues approximate natural tissue
structures
In bone, Haversian canal diameters vary with anatomical location and
with age (Cooper et al., 2007; Cvetkovic et al., 2013). In the human
femoral shaft, Haversian canal diameters can reach as high as
150.4 ± 118.9 μm and osteons reaching 252 ± 24 μm (Cooper et al.,
2007; Cvetkovic et al., 2013), putting our model and construct within
the anatomical range of Haversian canal diameters. However, the
microchannel distribution in our construct is 6.25/mm2, nearly half that
of the in vivo canal distribution. Per Zahm et al. (2010), a drop in oxygen
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available to cells as a function of distance from the microchannel is
expected but cell viablility can be maintained when a 100mmHg oxygen
partial pressure is prescribed. Our computational model matches this
outcome as it appears the saturated oxygen is sufficient to support cell
viability at the microchannel distribution designed into the SSuPer
tissue. However, given the greater density of natural bone, it is possible
that, as the density of the maturing biofabricated tissue increases closer
to that of natural bone, the microchannel distribution will not be
sufficient to support cell viability. In fact, Zahm et al. (2010) suggest that
the size of the osteon is limited by the diffusion distance of oxygen
through bone tissue surrounding the Haversian canal. The maturation of
biofabricated bone may therefore call for a higher microchannel density
in future constructs. To confirm this, more exhaustive studies, which are
beyond the scope of the current study, should provide controlled
oxygenation to investigate the oxygen availability and cell viability in the
interchannel spaces at varying microchannel distributions. In addition,
future studies should model the behavior of solutes of varying
sizes within the tissues including metabolites such as glucose and
growth factors.
Despite our study of bone in this manuscript, since the SSuPer
tissue method is an adjustable system, we can modify the oxygena-
tion concentration and tissue structure to match in vivo conditions
and tissue designs, respectively. Our article on oxygenation studies
wherein we control oxygen content in cell culture media and blood
using our FABRICA bioreactor is currently under review.
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